Image

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Comparing treatments for metastatic colorectal cancer with a specific KRAS mutation.

Recruiting
18 years and older
All
Phase 3

This study looks at whether a combination of drugs works better than the standard treatment for people with a specific type of colon cancer that has spread, known as metastatic colorectal cancer (mCRC). The cancer has a special mutation called KRAS p.G12C. Researchers will test if drugs like sotorasib and panitumumab combined with a treatment called FOLFIRI (a mix of chemotherapy drugs) fight the cancer better than FOLFIRI alone, with or without another drug called bevacizumab-awwb.

Participants must have not received any prior treatment for their cancer. They need to have the KRAS mutation confirmed and must be in good health overall, with their organs working well. Those with untreated brain cancer or certain lung conditions cannot join.

  • The study compares different treatments to see which keeps cancer from growing longer.
  • Participants must have a specific gene mutation and be in good general health.
  • Some health conditions might prevent joining the study.
Study details
    Metastatic Colorectal Cancer

NCT06252649

Amgen

8 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.